Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment with B-cell Depletion Therapy
Epistemonikos ID: 2ec2d0947f7d4288df4f941b8a96512e5019a4bd
First added on: Oct 25, 2025